General Counsel, Chief Compliance Officer and Secretary
Caryn joined Cytokinetics in May 2015 as our General Counsel.
Caryn has extensive experience advising dynamic biotechnology companies that are developing and commercializing therapeutics for high unmet medical needs and orphan diseases.
Most recently, Caryn served as Vice President, Deputy General Counsel and Assistant Secretary of InterMune, where she helped the company prepare for the U.S. approval and launch of Esbriet® (pirfenidone) as a treatment for idiopathic pulmonary fibrosis and played a leadership role in InterMune’s acquisition by Swiss drug maker Roche for more than $8 billion.
Earlier in her career, Caryn served in legal roles of increasing responsibility at Onyx Pharmaceuticals, Affymax, Inc., Genentech, and Millennium Pharmaceuticals. Prior to that, she served as Senior Counsel at the Office of the Inspector General (OIG) U.S. Department of Health and Human Services and as Assistant Attorney General Medicaid Fraud Control Unit of the Commonwealth of Massachusetts. She began her career as a litigator at Morrison Mahoney, LLP.
Ms. McDowell holds a J.D. from Boston University School of Law and a B.A. from the University of Michigan.
Caryn is a reformed marathoner, avid skier and die-hard Wolverine.